Early Detection of Chronic Kidney Disease | NCT06950151

Studies
Early Detection of Chronic Kidney Disease

NCT06950151

Sponsor

Consorci Sanitari de l'Alt Penedès i Garraf

Status

Completed

Last Update Posted

Dec 2, 2025Actual

Enrollment

345Actual

Phase

Not provided

Conditions

Chronic Kidney Diseases

Interventions

Not provided

Countries

Spain

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Dec 2025

Overall Recruitment Status or Expanded Access Status

Completed

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Apr 22, 2025Actual

Primary Completion Date

Oct 16, 2025Actual

Completion Date

Oct 16, 2025Actual

First Submitted Date

Apr 22, 2025

First Submission Date that Met QC Criteria

Apr 22, 2025

First Posted Date

Apr 30, 2025Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Dec 1, 2025

Last Update Posted Date

Dec 2, 2025Actual

Oversight Module

Has Data Monitoring Committee (DMC)

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

This retrospective observational study aims to assess the proportion of patients who were appropriately referred from primary care to the nephrology teleconsultation service. The appropriateness of the referral will be determined by the time elapsed between the referral criteria being met and the date of the teleconsultation, as well as by the patient's treatment at the time of referral.

Detailed Description

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

345Actual

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Chronic Kidney Disease Group		Patients with chronic kidney disease and at least one referral criterion for nephrology teleconsultation.

Interventions

Not provided

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Appropriate referral to teleconsultation	Proportion of patients referred to nephrology teleconsultation during 2024 in a timely manner and with appropriate treatment. Timely referral is defined as referral within three months of the appearance of nephrology referral criteria. Treatment adequacy will be assessed based on the recommendations of the SEMERGEN Primary Care guidelines and the therapeutic harmonization protocols established by CatSalut.	Baseline

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Men and women over 18 years of age
Teleconsultation to nephrology from Primary Care in the Garraf region during the period from January to December 2024
Patients with at least one referral criterion for the nephrology service

Exclusion Criteria:

Participants diagnosed with any of the following conditions:

Patients with Chronic Kidney Disease previously evaluated by the nephrology service.
History of requiring renal replacement therapy (hemodialysis, peritoneal dialysis, or kidney transplantation).
Patients hospitalized within the last 3 months with a diagnosis of kidney failure.
Patients with a known prior diagnosis of Autosomal Dominant Polycystic Kidney Disease or glomerular diseases.

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

Not provided

Standard Ages

AdultOlder Adult

Study Population

Patients with chronic kidney disease who are referred to nephrology teleconsultation from primary care

Sampling Method

Probability Sample

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Name	Affiliation	Role
Ignacio Manzur, MD	CSAPG	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Consorci Sanitari Alt Penedés-Garraf		Sant Pere de Ribes	Barcelona	08810	Spain

IPD Sharing Statement Module

Plan to Share IPD

Yes

Description

IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).

Types

Study Protocol

Time Frame

After publication of main results of the study.

Access Criteria

IPD will be shared only for scientific research purposes and following the Spanish and European Union normative law about data protection. The requirements will be directed to the IP of the study. The IP will evaluate the request to verify and evaluate the data that is requested and the purposes for which it is requested. Next, the IP will transfer the request to the promotor center the study for the final decision.

URL

Not provided

Condition Browse Module

MeSH Terms

ID	Term
D051436	Renal Insufficiency, Chronic

Ancestor Terms

ID	Term
D051437	Renal Insufficiency
D007674	Kidney Diseases
D014570	Urologic Diseases
D052776	Female Urogenital Diseases

Browse Leaves

Not provided

Browse Branches

Not provided